Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology. | Aging (Albany NY) | 2023 | 37285836 | PubTator, text mining | PubMed |
| Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy. | Front Oncol | 2023 | 37284197 | PubTator, text mining | PubMed |
| Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer. | Sci Rep | 2023 | 37277450 | PubTator, text mining | PubMed |
| Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma. | Front Immunol | 2023 | 37275878 | PubTator, text mining | PubMed |
| Therapeutic strategies to enhance immune response induced by multiple myeloma cells. | Front Immunol | 2023 | 37275861 | PubTator, text mining | PubMed |
| MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. | World J Gastroenterol | 2023 | 37274806 | PubTator, text mining | PubMed |
| In-depth mining of single-cell transcriptome reveals the key immune-regulated loops in age-related macular degeneration. | Front Mol Neurosci | 2023 | 37273909 | PubTator, text mining | PubMed |
| Immunotherapy in leukaemia. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37272727 | PubTator, text mining | PubMed |
| Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms. | Lung Cancer | 2023 | 37270937 | PubTator, text mining | PubMed |
| Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment. | Cancer Metastasis Rev | 2023 | 37266839 | PubTator, text mining | PubMed |
| Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease. | Front Immunol | 2023 | 37251379 | PubTator, text mining | PubMed |
| The Roles of Extracellular Vesicles in the Progression of Renal Cell Carcinoma and Their Potential for Future Clinical Application. | Nanomaterials (Basel) | 2023 | 37242027 | PubTator, text mining | PubMed |
| The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review. | Medicina (Kaunas) | 2023 | 37241198 | PubTator, text mining | PubMed |
| CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma. | Int J Mol Sci | 2023 | 37240076 | PubTator, text mining | PubMed |
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations. | Breast Cancer Res | 2023 | 37231433 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality. | J Clin Invest | 2023 | 37227784 | PubTator, text mining | PubMed |
| Systemic lupus erythematosus: latest insight into etiopathogenesis. | Rheumatol Int | 2023 | 37226016 | PubTator, text mining | PubMed |
| Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks. | Nat Aging | 2023 | 37217661 | PubTator, text mining | PubMed |
| Dysregulated MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus: A Comprehensive Review. | Int J Biol Sci | 2023 | 37215992 | PubTator, text mining | PubMed |
| Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma. | Front Oncol | 2023 | 37213288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=35